Population-based comparison of prognostic factors in invasive micropapillary and invasive ductal carcinoma of the breast

69Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Invasive micropapillary carcinoma (IMPC) is a variant of breast carcinoma with a higher propensity for lymph node metastases compared with invasive ductal carcinoma (IDC).Methods:Retrospective analysis of 636 IMPC and 297 735 IDC cases in the Surveillance, Epidemiology and End Results database comparing disease-specific survival (DSS) and overall survival (OS) between IMPC and IDC.Results:A higher percentage of IMPC cases (52.0%) had nodal metastases compared with IDC cases (34.6%). The 5-year DSS and OS for IMPC was 91.8% and 82.9%, respectively compared with 88.6% and 80.5% for IDC, respectively. For both IMPC and IDC, oestrogen-receptor positivity was associated with better survival, while having four or more positive lymph nodes or larger tumour size correlated with worse survival. Radiotherapy provided a survival benefit for both histological types.Conclusions:Despite IMPC's higher propensity for lymph node metastasis, IMPC has DSS and OS that compare favourably with IDC. © 2014 Cancer Research UK. All rights reserved.

Cite

CITATION STYLE

APA

Chen, A. C., Paulino, A. C., Schwartz, M. R., Rodriguez, A. A., Bass, B. L., Chang, J. C., & Teh, B. S. (2014). Population-based comparison of prognostic factors in invasive micropapillary and invasive ductal carcinoma of the breast. British Journal of Cancer, 111(3), 619–622. https://doi.org/10.1038/bjc.2014.301

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free